Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial. JACC. Cardiovascular imaging Mancini, G. B., Leipsic, J., Budoff, M. J., Hague, C. J., Min, J. K., Stevens, S. R., Reynolds, H. R., O'Brien, S. M., Shaw, L. J., Manjunath, C. N., Mavromatis, K., Demkow, M., Lopez-Sendon, J. L., Chernavskiy, A. M., Gosselin, G., Schuchlenz, H., Devlin, G. P., Chauhan, A., Bangalore, S., Hochman, J. S., Maron, D. J. 2021

Abstract

OBJECTIVES: This study aimed to examine the concordance of coronary computed tomographic angiography (CCTA) assessment of coronary anatomy and invasive coronary angiography (ICA) as the reference standard in patients enrolled in the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA).BACKGROUND: Performance of CCTA compared with ICA has not been assessed in patients with very high burdens of stress-induced ischemia and a high likelihood of anatomically significant coronary artery disease (CAD). A blinded CCTA was performed after enrollment to exclude patients with left main (LM) disease or no obstructive CAD before randomization to an initial conservative or invasive strategy, the latter guided by ICA and optimal revascularization.METHODS: Rates of concordance were calculated on a per-patient basis in patients randomized to the invasive strategy. Anatomic significance was defined as=50% diameter stenosis (DS) for both modalities. Sensitivity analyses using a threshold of=70% DS for CCTA or considering only CCTA images of good-to-excellent quality were performed.RESULTS: In 1,728 patients identified by CCTA as having no LM disease =50% and at least single-vessel CAD, ICA confirmed 97.1% without LM disease=50%, 92.2% with at least single-vessel CAD and no LM disease=50%, and only 4.9% without anatomically significant CAD. Results using a=70% DS threshold or only CCTA of good-to-excellent quality showed similar overall performance.CONCLUSIONS: CCTA before randomization in ISCHEMIA demonstrated high concordance with subsequent ICA for identification of patients with angiographically significant disease without LM disease.

View details for DOI 10.1016/j.jcmg.2020.11.012

View details for PubMedID 33454249